✉news WorldLaw & Courts first seen 1 d ago, last 1 d ago, peak #36
Court ruling favours United Therapeutics over Liquidia in patent fight
Original: Court ruling boosts United Therapeutics, slams Liquidia over pulmonary hypertension drug patent.
A court has ruled in favour of United Therapeutics in its patent dispute with Liquidia over a drug for pulmonary hypertension. The decision blocks Liquidia's competing treatment and strengthens United Therapeutics' position in the market. Investors reacted quickly, with United Therapeutics shares rising while Liquidia faced losses, and analysts are weighing the implications for future generic competition.
Why now: The ruling has direct financial consequences for both companies and their investors.
Evidence
- Court ruling boosts United Therapeutics, slams Liquidia over pulmonary hypertension drug patent. · Pluang
API: https://socialmediatrends-api.osmike.com/v1/trends/633140